135 related articles for article (PubMed ID: 37249821)
1. Interpersonal Values of Patients Participating in Phase II-III Clinical Trials: Implications for Clinical Trial Representativeness.
Gouveia R; Cruz VT; Antão J; Almeida L
Pharmaceut Med; 2023 Jul; 37(4):319-329. PubMed ID: 37249821
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980
[TBL] [Abstract][Full Text] [Related]
6. Psychological interventions for people with hemophilia.
Palareti L; Melotti G; Cassis F; Nevitt SJ; Iorio A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010215. PubMed ID: 32187661
[TBL] [Abstract][Full Text] [Related]
7. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
8. Interpersonal value profiles and analysis of adolescent academic performance and social thinking.
Gázquez JJ; Sainz J; Pérez-Fuentes Mdel C; Molero Mdel M; Soler FJ
Front Psychol; 2015; 6():575. PubMed ID: 25999891
[TBL] [Abstract][Full Text] [Related]
9. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
Younossi Z; Aggarwal P; Shrestha I; Fernandes J; Johansen P; Augusto M; Nair S
JHEP Rep; 2022 Sep; 4(9):100525. PubMed ID: 36039144
[TBL] [Abstract][Full Text] [Related]
10. [A four year study of the personal and interpersonal value systems of freshman nursing students at Yonsei University].
Choi YS
Taehan Kanho; 1991; 30(5):61-74. PubMed ID: 1779596
[TBL] [Abstract][Full Text] [Related]
11. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
12. Interpersonal Values and Academic Performance Related to Delinquent Behaviors.
Molero Jurado MD; Pérez Fuentes MD; Luque De La Rosa A; Martos Martínez Á; Barragán Martín AB; Simón Márquez MD
Front Psychol; 2016; 7():1480. PubMed ID: 27799914
[TBL] [Abstract][Full Text] [Related]
13. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
[TBL] [Abstract][Full Text] [Related]
14. Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
Loomba R; Morgan E; Watts L; Xia S; Hannan LA; Geary RS; Baker BF; Bhanot S
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):829-838. PubMed ID: 32553151
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
16. Is immediate imaging important in managing low back pain?
Andersen JC
J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
[TBL] [Abstract][Full Text] [Related]
17. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
18. Attitudes of Chinese Patients with Non-alcoholic Fatty Liver Disease Toward Participation in Clinical Trials from a National Multicenter Survey.
Huang R; Rao H; Lv F; Nan Y; Ren W; Huang Y; Li J; Tang H; Huang Y; Chalasani N; Wei L
Ther Innov Regul Sci; 2022 May; 56(3):464-473. PubMed ID: 35171499
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]